Carranza A, Nowicki S, Barontini M, Armando I
Centro de Investigaciones Endocrinológicas, Consejo Nacional de Investigaciones Científicas y Técnicas, 1425 Buenos Aires, Argentina.
Am J Physiol Renal Physiol. 2000 Jul;279(1):F77-83. doi: 10.1152/ajprenal.2000.279.1.F77.
This study assessed the role of adrenergic receptors on the regulation of the uptake of L-dopa and the production of dopamine by renal tubular cells. Scatchard analysis showed two L-dopa uptake sites with different affinities (K(m) 0.316 vs 1.53 microM). L-Dopa uptake was decreased by the nonselective adrenergic agonists epinephrine or norepinephrine (40%), by the beta-selective agonist isoproterenol or the beta(2)-selective agonist terbutaline (60%), but not by alpha-selective agonists (all 1 microM). The effect of norepinephrine, isoproterenol, or terbutaline was unaffected by addition of the beta(1)-antagonist atenolol, abolished by ICI-118, 551, a beta(2)-antagonist (both 0.1 microM), and mimicked by the addition of dibutyryl-cAMP (1 microM). Preincubation with terbutaline decreased the number of high-affinity uptake sites (V(max) = 1.10 +/- 0.3 vs. 0.5 +/- 0.1 pmol. mg protein(-1). min(-1)) without changing their affinity. Norepinephrine or terbutaline decreased dopamine production by isolated cells, and this effect was abolished by ICI-118,551 (0.1 microM). In vivo administration of ICI-118,551 reduced the urinary excretion of L-dopa and increased the excretion of 3,4-dihydroxyphenylacetic acid without significant changes in plasma L-dopa concentrations. These results demonstrate that stimulation of beta(2)-adrenergic receptors decreases the number of high-affinity L-dopa uptake sites in isolated tubular cells resulting in a reduction of the uptake of L-dopa and the production of dopamine and provide evidence for the presence of this mechanism in the intact animal.
本研究评估了肾上腺素能受体在肾小管细胞对左旋多巴摄取的调节及多巴胺生成中的作用。Scatchard分析显示有两个具有不同亲和力的左旋多巴摄取位点(K(m)分别为0.316和1.53微摩尔)。非选择性肾上腺素能激动剂肾上腺素或去甲肾上腺素(40%)、β选择性激动剂异丙肾上腺素或β(2)选择性激动剂特布他林(60%)可降低左旋多巴摄取,但α选择性激动剂(均为1微摩尔)则无此作用。去甲肾上腺素、异丙肾上腺素或特布他林的作用不受β(1)拮抗剂阿替洛尔的影响,而被β(2)拮抗剂ICI - 118,551(均为0.1微摩尔)消除,并可被添加二丁酰环磷腺苷(1微摩尔)模拟。用特布他林预孵育可减少高亲和力摄取位点的数量(V(max) = 1.10 ± 0.3对0.5 ± 0.1皮摩尔·毫克蛋白(-1)·分钟(-1)),而不改变其亲和力。去甲肾上腺素或特布他林可降低分离细胞的多巴胺生成,且该作用被ICI - 118,551(0.1微摩尔)消除。体内给予ICI - 118,551可降低左旋多巴的尿排泄,并增加3,4 - 二羟基苯乙酸的排泄,而血浆左旋多巴浓度无显著变化。这些结果表明,刺激β(2)肾上腺素能受体可减少分离肾小管细胞中高亲和力左旋多巴摄取位点的数量,导致左旋多巴摄取和多巴胺生成减少,并为完整动物中存在该机制提供了证据。